Anthony joined the Apogenics team in June 2012. Prior to joining Apogenics, Anthony was Vice President, Manufacturer Relations at a specialty group purchasing organization. In this role he was responsible for business development activities with pharma and biotech manufacturers. He led a team that focused on price concession and FFS based strategies and tactics across the spectrum of specialty products and specialty pharmacies. These strategies included contracting, data aggregation, patient and provider initiatives and third party vendor coordination.
Previously, Anthony held various roles in Trade Relations, Strategic Pricing and Finance at Roche Laboratories where he honed his Economic Analysis, New and Inline Pricing, Contracting and Strategy skills across primary care and specialty products in the clinic, hospital, GPO, Payer (Public and Private), Retail, Specialty Pharmacy and Wholesaler and Distributor classes of trade.